NTP-42

N/A

Report date: 2025/01/20 10:34:37
NME

Base Information

Drug NameNTP-42
Drug Alias NameNTP-42NTP42:KVA4
ClassificationSmall molecules
Mechanisms of ActionThromboxane A2 receptor antagonists
TargetsThromboxane A2 receptor
Therapy Area/IndicationsUrogenital DiseasesHeart FailureCardiovascular Diseases +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIrelandUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesATXA Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesATXA Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsHeart FailurePulmonary Arterial Hypertension
Inactive IndicationsUrogenital DiseasesCardiovascular DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A